Page last updated: 2024-10-27

flecainide and Isolated Non-compaction of the Ventricular Myocardium

flecainide has been researched along with Isolated Non-compaction of the Ventricular Myocardium in 1 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nozaki, Y1
Kato, Y1
Uike, K1
Yamamura, K1
Kikuchi, M1
Yasuda, M1
Ohno, S1
Horie, M1
Murayama, T1
Kurebayashi, N1
Horigome, H1

Other Studies

1 other study available for flecainide and Isolated Non-compaction of the Ventricular Myocardium

ArticleYear
Co-Phenotype of Left Ventricular Non-Compaction Cardiomyopathy and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia in Association With R169Q, a Ryanodine Receptor Type 2 Missense Mutation.
    Circulation journal : official journal of the Japanese Circulation Society, 2020, 01-24, Volume: 84, Issue:2

    Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Calcium Signaling; Child; Child, Preschool; Dea

2020